| scholarly article | Q13442814 |
| P50 | author | Stefano Menini | Q43252011 |
| Flavia Pricci | Q47504388 | ||
| P2093 | author name string | Carlo Ricci | |
| Giuseppe Pugliese | |||
| Francesco Pugliese | |||
| Carla Iacobini | |||
| Giovanna Oddi | |||
| Lorena Amadio | |||
| Mariella Sorcini | |||
| Clelia Di Pippo | |||
| P2860 | cites work | Expression of galectin-3 modulates T-cell growth and apoptosis | Q24309392 |
| Oxidants, oxidative stress and the biology of ageing | Q28131725 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway | Q28572708 | ||
| Epsilon BP, a beta-galactoside-binding animal lectin, recognizes IgE receptor (Fc epsilon RI) and activates mast cells | Q28572966 | ||
| N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression | Q28645594 | ||
| Why do we age? | Q29615672 | ||
| Protein glycation, diabetes, and aging | Q32120059 | ||
| Gene expression in aging kidney and pituitary. | Q33202829 | ||
| Nitrosation and oxidation in the regulation of gene expression | Q34056377 | ||
| Transcription factor-kappa B (NF-kappa B) and renal disease. | Q34135831 | ||
| Aging and proinflammatory cytokines | Q34219483 | ||
| Oxidative damage to mitochondria and aging | Q34280171 | ||
| Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes | Q34662319 | ||
| Identification of galectin-3 as a factor in pre-mRNA splicing | Q34706659 | ||
| An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. | Q35081898 | ||
| The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration. | Q35103388 | ||
| Kidney function in older people: pathology, assessment and management | Q35179570 | ||
| Role of galectin-3 in diabetic nephropathy | Q35182376 | ||
| Involvement of Rel/NF-kappa B transcription factors in senescence. | Q35617919 | ||
| Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. | Q35809897 | ||
| Free radicals and aging. | Q35890767 | ||
| Breakers of advanced glycation end products restore large artery properties in experimental diabetes. | Q36477705 | ||
| Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. | Q37308593 | ||
| Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. | Q37363088 | ||
| The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation | Q38313494 | ||
| Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. | Q41172028 | ||
| The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. | Q42491067 | ||
| Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. | Q43565214 | ||
| 15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes | Q43664164 | ||
| Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. | Q43786750 | ||
| Glomerular number and size in relation to age, kidney weight, and body surface in normal man | Q44090511 | ||
| Determinants of glomerular hypofiltration in aging humans. | Q46702105 | ||
| Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. | Q47999828 | ||
| Age-related changes in the regulation of transcription factor NF-kappa B in rat brain | Q48758724 | ||
| Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress | Q50180621 | ||
| Age-dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parenteral administration of ferric nitrilotriacetate commensurate with its differential toxicity: implications for the involvement of HNE-protein adducts in o | Q53424252 | ||
| Role of advanced glycation end-products (AGE) in late diabetic complications. | Q53709041 | ||
| P433 | issue | 3 | |
| P921 | main subject | knockout mouse | Q1364740 |
| P304 | page(s) | F611-21 | |
| P577 | publication date | 2005-05-03 | |
| P1433 | published in | American Journal of Physiology - Renal Physiology | Q2610177 |
| P1476 | title | Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice | |
| P478 | volume | 289 |
| Q38317758 | Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function |
| Q41628398 | Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin. |
| Q42906216 | Arginase II: atherogenesis beyond enzyme activity |
| Q37234937 | Cell cycle arrest in a model of colistin nephrotoxicity |
| Q33754895 | Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive Treatment |
| Q36159048 | D-Carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation. |
| Q34587928 | Galectin-3 associates with the primary cilium and modulates cyst growth in congenital polycystic kidney disease |
| Q38542678 | Galectin-3 in autoimmunity and autoimmune diseases |
| Q37738648 | Galectin-3 in cardiac remodeling and heart failure |
| Q33972695 | Galectin-3 is a new MerTK-specific eat-me signal |
| Q34501897 | Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis |
| Q38258947 | Galectin-3: an emerging all-out player in metabolic disorders and their complications |
| Q37983646 | Galectins in acute and chronic inflammation |
| Q41134548 | Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease |
| Q26799443 | Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade |
| Q34603941 | Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice |
| Q53137711 | Inflammation and insulin resistance: New targets encourage new thinking: Galectin-3 and LTB4 are pro-inflammatory molecules that can be targeted to restore insulin sensitivity. |
| Q38108373 | Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology. |
| Q37268238 | Of cardiovascular illness and diversity of biological response |
| Q41695164 | Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy |
| Q48030329 | The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation. |
| Q38945365 | Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease |
| Q30318169 | [Protein glycation as a pathological mechanism in diabetes]. |
Search more.